- NEWS
Merck’s COVID pill loses its lustre: what that means for the pandemic
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-021-03667-0
COVID antiviral pills: what scientists still want to know
How antiviral pill molnupiravir shot ahead in the COVID drug hunt
The race for antiviral drugs to beat COVID — and the next pandemic